发明名称 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMOD
摘要 This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with fingolimod. This invention also provides a package and a pharmaceutical composition comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with fingolimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fingolimod in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
申请公布号 EP2766020(A1) 申请公布日期 2014.08.20
申请号 EP20120840715 申请日期 2012.10.11
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 HALLAK, HUSSEIN;TARCIC, NORA;FLAXMAN KAYE, JOEL
分类号 A61K31/47;A61K31/035;A61K31/135;A61K31/137;A61K31/4704 主分类号 A61K31/47
代理机构 代理人
主权项
地址